Page last updated: 2024-10-27

fluorouracil and Minimal Disease, Residual

fluorouracil has been researched along with Minimal Disease, Residual in 153 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research Excerpts

ExcerptRelevanceReference
"For patients who have significant residual tumor after resection or relapse after radiation, the proper chemotherapy regimen has not yet been identified."6.72Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children. ( Ahn, SD; Ghim, TT; Goo, HW; Khang, SK; Kim, YJ; Lee, MJ; Park, JB; Ra, YS; Song, JS, 2006)
"Sequential doxorubicin/paclitaxel (AT) followed by CMF treatment was shown to be an active neoadjuvant chemotherapy regimen in the first European Cooperative Trial in Operable Breast Cancer (ECTO I trial)."5.16Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II). ( Bari, M; Ciruelos, E; De Benedictis, E; Dittrich, C; Gaion, F; Gomez, P; Lluch, A; Luca, G; Mansutti, M; Morandi, P; Pavesi, L; Semiglazov, V; Valagussa, P; Zamagni, C; Zambetti, M, 2012)
" Surgery Division of Verona University, 155 consecutive patients with locally advanced esophageal cancers (90 SCC, 65 adenocarcinoma) were treated with a single protocol of neoadjuvant CRT (docetaxel, cisplatin, and 5-fluorouracil with 50."3.79Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center. ( Casella, F; de Manzoni, G; Giacopuzzi, S; Pasini, F; Verlato, G; Weindelmayer, J; Zanoni, A; Zhao, E, 2013)
"We included 199 patients with HER2+ breast cancer from three successive cohorts of neo-adjuvant chemotherapy on the basis of paclitaxel (Taxol) (P) administered weekly (w) or three weekly (3-w), followed by 5-fluorouracil (F), doxorubicin (A) or epirubicin (E), and cyclophosphamide (C)."3.74Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab. ( Buzdar, AU; Dawood, SS; Esteva, FJ; Gonzalez-Angulo, AM; Green, MC; Hatzis, C; Hortobagyi, GN; Kuerer, HM; Mejia, JA; Peintinger, F; Pusztai, L; Symmans, WF, 2008)
"Resection specimens from 47 cases of oesophageal adenocarcinoma treated with preoperative 5-fluorouracil/cisplatin and radiotherapy were reviewed."3.71A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy. ( Dunne, B; Griffin, M; Kelly, A; Mulligan, E; Reynolds, JV, 2001)
"IC with paclitaxel or FAC resulted in effective downstaging of primary tumors and axillary metastases in patients with Stage IIA, IIB, and IIIA breast carcinoma."3.70The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy. ( Ames, FC; Buzdar, AU; Feig, BW; Hunt, KK; Lenert, JT; Mirza, NQ; Ross, MI; Singletary, SE; Vlastos, G, 2000)
"Patients with stage II or stage IIIC colon cancer with positive ctDNA results (tested as standard of care with commercial testing) will be eligible for enrollment in cohort B."3.11Minimal Residual Disease-Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US. ( Dasari, A; Deming, D; George, TJ; Kopetz, S; Lieu, CH; Lin, Y; Lucas, PC; Sahin, IH; Yothers, G, 2022)
"In the remaining seven (20%), the residual tumour clinically appeared benign."2.82Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign. ( Bujko, K; Malinowska, M; Mroz, A; Pietrzak, L; Rupinski, M; Rutkowski, A; Szczepkowski, M; Wyrwicz, L, 2016)
"Overall accuracy of the residual cancer burden score determination was 0."2.80Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy. ( Albarracin, C; Downs-Kelly, E; Gould, R; Hatzis, C; Morkowski, J; Peintinger, F; Sinn, B; Symmans, WF, 2015)
"Patients with cT3-4, any N, any M rectal cancer were eligible."2.79Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer. ( Birnbaum, E; Fleshman, J; Gao, F; Hall, L; Hunt, S; Kodner, I; Lockhart, AC; Mutch, M; Myerson, RJ; Naughton, M; Olsen, J; Parikh, P; Picus, J; Rigden, C; Safar, B; Sorscher, S; Suresh, R; Tan, B; Wang-Gillam, A, 2014)
"The presence of residual tumour by conventional imaging, dichotomised as positive or negative, and the level of FDG uptake (standardised uptake values, SUV) were compared with histopathology, which served as the reference standard."2.75Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer. ( Avril, N; Avril-Sassen, S; Dose-Schwarz, J; Jänicke, F; Lebeau, A; Mahner, S; Schwaiger, M; Tiling, R; Untch, M; Weber, C, 2010)
"Patients with advanced esophageal squamous cell carcinoma receive neoadjuvant chemotherapy or chemoradiotherapy to improve survival, but benefits are observed only in those with histologic response."2.73Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma. ( Doki, Y; Fujiwara, Y; Fukunaga, H; Hatazawa, J; Higuchi, I; Miyata, H; Monden, M; Takiguchi, S; Tatsumi, M; Yano, M; Yasuda, T, 2008)
"For patients who have significant residual tumor after resection or relapse after radiation, the proper chemotherapy regimen has not yet been identified."2.72Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children. ( Ahn, SD; Ghim, TT; Goo, HW; Khang, SK; Kim, YJ; Lee, MJ; Park, JB; Ra, YS; Song, JS, 2006)
"Approximately 1 out of 10 advanced rectal cancers after preoperative radiotherapy or radiochemotherapy was characterized by DIS of over 5 mm."2.72Distal intramural spread of rectal cancer after preoperative radiotherapy: the results of a multicenter randomized clinical study. ( Bujko, K; Chmielik, E; Huzarski, T; Karmolinski, A; Kepka, L; Majewski, P; Nasierowska-Guttmejer, A; Nowacki, MP; Sopylo, R; Sygut, J; Wandzel, P; Wojnar, A, 2006)
"Forty patients with locally advanced breast carcinoma underwent neoadjuvant chemotherapy."2.71Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. ( Arbion, F; Body, G; Brunereau, L; Chapiron, C; Denis, F; Desbiez-Bourcier, AV, 2004)
"Peritoneal carcinomatosis in the absence of distant metastasis occurs in approximately 8 per cent of patients with colorectal cancer."2.71Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy. ( van Ruth, S; van Tinteren, H; Verwaal, VJ; Zoetmulder, FA, 2004)
"Clinical response and residual tumor size were evaluated in 108 treated patients who completed a clinical trial with paclitaxel and then received combined 5-fluorouracil, doxorubicin, and cyclophosphamide chemotherapy."2.71Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response. ( Buzdar, AU; Fiterman, DJ; Frye, D; Gal-Gombos, E; Green, M; Hortobagyi, GN; Kuerer, H; Poniecka, A; Pusztai, L; Rajan, R; Rouzier, R; Smith, TL; Symmans, WF; Whitman, G; Yang, Y, 2004)
"All patients had surgically documented minimal residual disease (1."2.68Intraperitoneal administration of cisplatin and 5-fluorouracil in residual ovarian cancer: a Phase II Gynecologic Oncology Group trial. ( Averette, H; Berek, JS; Blessing, JA; Braly, PS; Homesley, HD, 1995)
"Treatment of both Hodgkin's disease (HD) and high-grade non-Hodgkin's lymphoma (HG-NHL) with bulky presentation at diagnosis frequently results in residual masses detected radiologically."2.68Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma. ( Babini, L; Barbieri, E; Battista, G; Bendandi, M; Canini, R; Fanti, S; Frezza, G; Gherlinzoni, F; Gozzetti, A; Merla, E; Monetti, N; Pisi, P; Rimondi, MR; Tura, S; Zinzani, PL; Zompatori, M, 1996)
"Patients with residual tumor on posttreatment biopsy were treated with a salvage regimen that consisted of additional pelvic RT (9 Gy), 5-FU, and cisplatin (100 mg/m2)."2.68Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. ( Coia, L; Doggett, S; Flam, M; John, M; Kerman, H; Murray, K; Myerson, R; Pajak, TF; Petrelli, N; Quivey, J; Rotman, M, 1996)
"Treatment of esophageal cancer has been primarily palliative."2.68Treating esophageal cancer with a combination of chemotherapy, radiation, and excision. ( Bates, DM; Clyde, JC; Garcia, JM; Girvin, GW; Lin, PH; Matsumoto, GH, 1995)
"The majority of anal cancers are squamous cell carcinomas, and they are treated according to stage."2.52Anal cancer treatment: current status and future perspectives. ( Abdayem, P; Antoun, J; Ghosn, M; Kourie, HR; Nasr, D, 2015)
"From a global perspective, gastric cancer including cancer of the esophago-gastric junction is the fourth most common malignant tumor and the second-most common cause of cancer-related death."2.46[Diagnosis and treatment of gastric cancer]. ( Ebert, M; Grenacher, L; Lordick, F; Moehler, M; Röcken, C; Schumacher, G, 2010)
"Eighty percent of the patients had squamous cell carcinoma and 20% had adenocarcinoma."2.39Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. ( Bates, BA; Bernard, SA; Detterbeck, FC; Qaqish, BF; Tepper, JE, 1996)
"When treating invasive basal cell carcinoma (BCC) with Mohs micrographic surgery (MMS), including infiltrative and nodular subtypes, the goal is complete surgical removal of the tumor."1.56Topical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery. ( Housewright, C; Pederson, H; Staples, CJ, 2020)
"Pathologists assess rectal cancers that have responded significantly to neoadjuvant therapy more thoroughly."1.51Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After Chemoradiation. ( Avila, K; Chow, OS; Chu, P; Garcia-Aguilar, J; Keskin, M; Patil, S; Shia, J; Smith, DD; Smith, JJ; Widmar, M, 2019)
"Management of advanced intrahepatic cholangiocarcinoma (iCCA) is challenging and overall survival is poor."1.51Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden. ( Gbolahan, O; Hashemi-Sadraei, N; O'Neil, B, 2019)
"Data were analyzed from a prospective pancreatic cancer database."1.48Resection of Locally Advanced Pancreatic Cancer without Regression of Arterial Encasement After Modern-Era Neoadjuvant Therapy. ( Chabot, JA; Hecht, EM; Kluger, MD; Rashid, MF; Rosario, VL; Schrope, BA; Steinman, JA, 2018)
"Among 496 consecutive M1c colorectal cancer patients, R0 resection was achieved for 94 patients (19%)."1.48Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy. ( Kanemitsu, Y; Ochiai, H; Shida, D; Tsukamoto, S, 2018)
"The presence of LNS in ypN0 rectal cancer patients after chemoradiotherapy should not be considered a factor for a poor prognosis."1.46Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer. ( Agostini, J; Benoist, S; Boige, V; Brouquet, A; Dartigues, P; Dumont, F; Goéré, D; Julié, C; Lazure, T; Penna, C; Peschaud, F; Vychnevskaia, K, 2017)
"A pathologic cervical residual tumor was observed in 16 patients (35."1.43[Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy]. ( Ballester, M; Daraï, E; Huguet, F; Lauratet, B; Lefranc, JP; Monnier, L; Touboul, E, 2016)
"Nine days after CAF treatment, residual tumors showed features of regressive alterations and were composed of mesenchymal-like tumor cells, infiltrating immune cells and some tumor-associated fibroblasts with an intense deposition of collagen."1.42Chemotherapy of WAP-T mouse mammary carcinomas aggravates tumor phenotype and enhances tumor cell dissemination. ( Alves, F; Deppert, W; Jannasch, K; Lenfert, E; Maenz, C; Wegwitz, F, 2015)
"A total of 377 patients with breast cancer who received preoperative chemotherapy were included in this retrospective study."1.42Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy. ( Bago-Horvath, Z; Bartsch, R; Bergen, E; Dubsky, P; Exner, R; Gnant, M; Jakesz, R; Mittlböck, M; Ott, J; Panhofer, P; Promberger, R; Rudas, M; Seemann, R; Singer, C; Steger, G, 2015)
"Three and five years survival of gastric cancer patients subjected to adjuvant chemoradiotherapy was 53 and 41% respectively."1.40[Adjuvant chemoradiotherapy in advanced gastric cancer: experience in 168 patients]. ( Isa O, N; López V, H; Russo N, M, 2014)
"Esophageal obstruction prior to CCRT, residual tumor according to the first follow-up endoscopy, and poor follow-up computed tomography responses were significantly associated with locoregional failure."1.40Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation. ( Kim, HW; Kim, JH; Kim, JW; Lee, CG; Lee, IJ; Lee, YC; Park, H; Park, JJ; Youn, YH, 2014)
"Twenty-five patients with T3/T4N0 or N+ rectal cancer were enrolled."1.39Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor. ( Broggi, S; Calandrino, R; De Cobelli, F; De Nardi, P; Di Muzio, N; Di Palo, S; Fiorino, C; Iacovelli, NA; Losio, C; Orsenigo, E; Passoni, P; Ricci, V; Ronzoni, M; Slim, N; Staudacher, C; Tamburini, A, 2013)
"Patients with small residual tumors (≤3 cm) radiologically staged ycT0-2N0 were treated by transanal endoscopic microsurgery."1.39Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution. ( Bianchi, R; Gama-Rodrigues, J; Habr-Gama, A; Lynn, PB; Perez, RO; Proscurshim, I; São Julião, GP, 2013)
"A mucinous carcinoma was found in 21 of 88 patients."1.38Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. ( Düber, C; Hansen, T; Heintz, A; Hötker, AM; Junginger, T; Kreft, A; Kreitner, KF; Menig, M; Oberholzer, K; Schmidberger, H; Schneider, A, 2012)
"We obtained total RNA from residual cancer cells using microdissection from a total of 52 rectal cancer specimens from patients who underwent preoperative CRT."1.38Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy. ( Fujikawa, H; Inoue, Y; Kusunoki, M; Matsushita, K; Okugawa, Y; Saigusa, S; Tanaka, K; Toiyama, Y; Uchida, K, 2012)
"In 10-24% of patients with rectal cancer who are treated with neoadjuvant chemoradiation, no residual tumor is found after surgery (ypT0)."1.37Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. ( Bakers, FC; Barbaro, B; Beets, GL; Beets-Tan, RG; Haustermans, K; Lambrecht, M; Lambregts, DM; Maas, M; Valentini, V; Vandecaveye, V, 2011)
"One hundred and fourteen cases of breast cancer with NA therapy were analyzed and clinical data were collected from March 2007 to December 2010."1.37[Primary systemic therapy in breast cancer patients (2007-2010)]. ( Farkas, R; Horváth, OP; Kálmán, E; Kovács, G; Kövér, E; Pavlovics, G; Szalai, G; Tizedes, G; Zapf, I, 2011)
"Thirty-three patients with rectal cancer underwent preoperative CRT."1.35Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. ( Ioue, Y; Kusunoki, M; Miki, C; Okugawa, Y; Saigusa, S; Tanaka, K; Toiyama, Y; Yokoe, T, 2009)
"Five patients had less than one-third residual tumor cells in resected specimens histopathologically; eight had more than two-thirds residual tumor cells."1.35Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer. ( Kusunoki, M; Miki, C; Mohri, Y; Ohi, M; Otake, K; Tanaka, K; Toiyama, Y; Tonouchi, H; Yokoe, T, 2009)
"The incidence of gallbladder cancer (GBC) in the US is 1."1.35Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). ( Abou-Alfa, GK; Blumgart, LH; Capanu, M; D'Angelica, M; Dematteo, RP; Duffy, A; Fong, Y; Huitzil, D; Jarnagin, W; O'Reilly, EM, 2008)
"Fifty patients with advanced squamous cell carcinoma of the head and neck (SSCHN) who underwent MRI volumetry before and after neoadjuvant chemotherapy consisting of docetaxel, cisplatin, and 5-fluorouracil (TPF) were included in this study."1.34Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy. ( Baghi, M; Bisdas, S; Gstoettner, W; Hambek, M; Knecht, R; Mack, MG; Muerthel, R; Vogl, T; Wagenblast, J, 2007)
"Delayed recurrences, common in breast cancer, are well explained by the concept of tumour dormancy."1.34Tumour dormancy in breast cancer: an update. ( Brackstone, M; Chambers, AF; Townson, JL, 2007)
"Complete response (no residual tumour, TRG 1) was seen in 7% of the patients (3/44) and total or major regression (TRG 1-3) in 73% of the patients (32/44) treated with 50-Gy chemoradiation."1.33Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma. ( Jantunen, I; Juhola, M; Kairaluoma, M; Kellokumpu, I; Vironen, J, 2005)
"Seventy-seven patients with primary breast cancer who had undergone neoadjuvant anthracycline-based chemotherapy were included in the present study."1.33Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival. ( Alberti, S; Angelucci, D; Cianchetti, E; Ficorella, C; Iacobelli, S; Lattanzio, R; Marchetti, P; Natoli, C; Piantelli, M; Ricevuto, E; Tinari, N, 2006)
"Tegafur levels were also higher in tumor samples than other sites (mean 3446."1.33Tegafur and 5-fluorouracil pelvic tissue concentrations in rectal cancer patients receiving preoperative chemoradiation. ( Aldaz, A; Alvarado, A; Arranz, JA; Calvo, FA; de la Mata, D; García, R; Giráldez, J; Serrano, J; Zufía, L, 2006)
"Diarrhea was the most frequent acute toxicity."1.31Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. ( Hagihara, PF; John, WJ; Kenady, DE; Marks, G; McGrath, PC; Mohiuddin, M; Regine, WF, 2000)
"For locally advanced primary colorectal cancer, our institution has combined intraoperative electron irradiation (IOERT) with external beam irradiation (EBRT) +/- 5-fluorouracil (5-FU) and surgical resection."1.30Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/- 5-FU. ( Cha, S; Devine, R; Dozois, R; Fieck, JM; Gunderson, LL; Haddock, M; Martenson, JA; Nelson, H; O'Connell, MJ; Wolff, B, 1997)
"5-Fluorouracil was administered at an initial daily dose of 125 mg/m2, with dose escalation planned in 25-mg increments, depending on patient tolerance."1.30Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer. ( Burch, PA; Garton, GR; Kugler, JW; Martenson, JA; Pitot, HC; Santala, RG; Schroeder, G; Stella, PJ; Swaminathan, R; Wright, K, 1997)
"Thirteen (23%) of 56 women had no residual tumor."1.29Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy. ( Adler, DD; Cody, RL; Helvie, MA; Joynt, LK; Merajver, SD; Pierce, LJ, 1996)
" Our preliminary data indicate that postradiation adjuvant chemotherapy with a weekly FP regimen at our dosage is not recommended for high-risk NPC."1.29Preliminary report of outpatient weekly adjuvant chemotherapy for high-risk nasopharyngeal carcinoma. ( Hsu, CY; Jan, JS; Lin, JC, 1996)
"All specimens showed residual tumour in the mastectomy specimen or the regional lymph nodes."1.29Locally advanced breast cancer: is surgery warranted following chemotherapy? ( Eaton, M; Humeniuk, V; Kent, AL; Marshall, N, 1995)

Research

Studies (153)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's33 (21.57)18.2507
2000's49 (32.03)29.6817
2010's64 (41.83)24.3611
2020's7 (4.58)2.80

Authors

AuthorsStudies
Murray, NP1
Villalon, R1
Hartmann, D1
Rodriguez, PM1
Aedo, S1
Sahin, IH2
Lin, Y1
Yothers, G1
Lucas, PC1
Deming, D1
George, TJ1
Kopetz, S1
Lieu, CH1
Dasari, A1
Manceau, G1
Margot, N1
Augustin, J1
Bardier, A1
Simon, JM1
Bachet, JB1
Spano, JP1
Maingon, P1
Vaillant, JC1
Karoui, M1
Akiyoshi, T1
Toda, S1
Tominaga, T1
Oba, K1
Tomizawa, K1
Hanaoka, Y1
Nagasaki, T1
Konishi, T1
Matoba, S1
Fukunaga, Y1
Ueno, M1
Kuroyanagi, H1
Pederson, H1
Staples, CJ1
Housewright, C1
von der Lippe Gythfeldt, H1
Lien, T1
Tekpli, X1
Silwal-Pandit, L1
Borgen, E1
Garred, Ø1
Skjerven, H1
Schlichting, E1
Lundgren, S1
Wist, E1
Naume, B1
Kristensen, V1
Børresen-Dale, AL1
Lingjaerde, OC1
Engebraaten, O1
Barrak, D1
Desale, S1
Yoon, JJ1
Dugan, MM1
Kodavanti, PP1
Sampah, ME1
Sugarbaker, PH2
Bigness, A1
Imanirad, I1
Xie, H1
Frakes, J1
Hoffe, S1
Laskowitz, D1
Felder, S1
Epelboym, I1
Zenati, MS1
Hamad, A1
Steve, J1
Lee, KK1
Bahary, N1
Hogg, ME1
Zeh, HJ1
Zureikat, AH1
Tsang, JS1
Tong, DKH1
Lam, KO1
Law, BTT1
Wong, IYH1
Chan, DKK1
Chan, FSY1
Kwong, D1
Law, S1
Kluger, MD1
Rashid, MF1
Rosario, VL1
Schrope, BA1
Steinman, JA1
Hecht, EM1
Chabot, JA1
Berriochoa, CA1
Abdel-Wahab, M1
Leyrer, CM1
Khorana, A1
Matthew Walsh, R1
Kumar, AMS1
Shida, D1
Tsukamoto, S1
Ochiai, H1
Kanemitsu, Y1
Fokas, E1
Ströbel, P1
Fietkau, R1
Ghadimi, M1
Liersch, T1
Grabenbauer, GG1
Hartmann, A1
Kaufmann, M1
Sauer, R1
Graeven, U1
Hoffmanns, H1
Raab, HR1
Hothorn, T1
Wittekind, C1
Rödel, C1
Takemoto, K1
Miyahara, N1
Chikuie, N1
Hamamoto, T1
Ishino, T1
Ueda, T1
Takeno, S1
Chow, OS1
Patil, S1
Keskin, M1
Smith, JJ1
Widmar, M1
Smith, DD1
Avila, K1
Shia, J1
Chu, P1
Garcia-Aguilar, J1
Li, Z1
Xiao, D1
Li, X1
Zhan, P1
Wang, J2
Zhang, H1
Yoon, G1
Park, JY1
Kim, HJ1
Choi, GS1
Kim, JG1
Kang, BW1
Kang, MK1
Seo, AN1
Oguma, J1
Ozawa, S1
Koyanagi, K1
Kazuno, A1
Yamamoto, M1
Ninomiya, Y1
Yatabe, K1
Gbolahan, O1
Hashemi-Sadraei, N1
O'Neil, B1
Passoni, P1
Fiorino, C1
Slim, N1
Ronzoni, M1
Ricci, V1
Di Palo, S1
De Nardi, P1
Orsenigo, E1
Tamburini, A1
De Cobelli, F1
Losio, C1
Iacovelli, NA1
Broggi, S1
Staudacher, C1
Calandrino, R1
Di Muzio, N1
Hequet, D1
Marchand, E1
Place, V1
Fourchotte, V1
De La Rochefordière, A1
Dridi, S1
Coutant, C1
Lecuru, F1
Bats, AS1
Koskas, M1
Bretel, JJ1
Bricou, A1
Delpech, Y1
Barranger, E1
Shimada, H1
Nagata, M1
Cho, A1
Takiguchi, N1
Kainuma, O1
Soda, H1
Ikeda, A1
Nabeya, Y1
Yajima, S1
Yamamoto, H2
Sugiyama, T1
Itami, M1
Kim, GJ1
Koshy, M1
Hanlon, AL1
Horiba, MN1
Edelman, MJ1
Burrows, WM1
Battafarano, RJ1
Suntharalingam, M1
Myerson, RJ1
Tan, B1
Hunt, S1
Olsen, J1
Birnbaum, E1
Fleshman, J1
Gao, F1
Hall, L1
Kodner, I1
Lockhart, AC1
Mutch, M1
Naughton, M1
Picus, J1
Rigden, C1
Safar, B1
Sorscher, S1
Suresh, R1
Wang-Gillam, A1
Parikh, P1
Isa O, N1
Russo N, M1
López V, H1
Swellengrebel, HA1
Bosch, SL1
Cats, A1
Vincent, AD1
Dewit, LG1
Verwaal, VJ2
Nagtegaal, ID1
Marijnen, CA1
Park, HJ1
Kim, K2
Chie, EK2
Jang, JY2
Kim, SW2
Han, SW2
Oh, DY2
Im, SA2
Kim, TY2
Bang, YJ2
Ha, SW2
Jannasch, K1
Wegwitz, F1
Lenfert, E1
Maenz, C1
Deppert, W1
Alves, F1
Kim, HW1
Kim, JH3
Lee, IJ1
Kim, JW1
Lee, YC1
Lee, CG1
Park, JJ1
Youn, YH1
Park, H1
Mombelli, S1
Kwiatkowski, F1
Abrial, C1
Wang-Lopez, Q1
de Boissieu, P1
Garbar, C1
Bensussan, A1
Curé, H1
Malik, H1
Khan, AZ1
Berry, DP1
Cameron, IC1
Pope, I1
Sherlock, D1
Helmy, S1
Byrne, B1
Thompson, M1
Pulfer, A1
Davidson, B1
Ghosn, M1
Kourie, HR1
Abdayem, P1
Antoun, J1
Nasr, D1
Yokota, T1
Ando, N1
Igaki, H1
Shinoda, M1
Kato, K1
Mizusawa, J1
Katayama, H1
Nakamura, K1
Fukuda, H1
Kitagawa, Y1
Peintinger, F2
Sinn, B2
Hatzis, C3
Albarracin, C1
Downs-Kelly, E1
Morkowski, J1
Gould, R2
Symmans, WF5
Chiu, CH1
Chen, WH1
Wen, YW1
Yeh, CJ1
Chao, YK1
Chang, HK1
Tseng, CK1
Liu, YH1
Promberger, R1
Dubsky, P1
Mittlböck, M1
Ott, J1
Singer, C1
Seemann, R1
Exner, R1
Panhofer, P1
Steger, G1
Bergen, E1
Gnant, M1
Jakesz, R1
Bago-Horvath, Z1
Rudas, M1
Bartsch, R1
Rupinski, M1
Szczepkowski, M1
Malinowska, M1
Mroz, A1
Pietrzak, L1
Wyrwicz, L1
Rutkowski, A1
Bujko, K2
Monnier, L1
Touboul, E1
Daraï, E1
Lefranc, JP1
Lauratet, B1
Ballester, M1
Huguet, F1
Ueki, T1
Manabe, T1
Inoue, S1
Ienaga, J1
Yamanaka, N1
Egami, T1
Ishikawa, M1
Konomi, H1
Ikubo, A1
Nagayoshi, K1
Nakamura, M1
Tanaka, M1
Dai, Y1
Wang, L1
Tang, J1
Cao, P1
Luo, Z1
Sun, J1
Kiflu, A1
Sai, B1
Zhang, M1
Wang, F1
Li, G1
Xiang, J1
Katz, MH1
Shi, Q1
Ahmad, SA1
Herman, JM1
Marsh, Rde W1
Collisson, E1
Schwartz, L1
Frankel, W1
Martin, R1
Conway, W1
Truty, M1
Kindler, H1
Lowy, AM1
Bekaii-Saab, T1
Philip, P1
Talamonti, M1
Cardin, D1
LoConte, N1
Shen, P1
Hoffman, JP1
Venook, AP1
Ma, Y1
Zhang, S1
Zang, L1
Li, J2
Kang, Y1
Ren, W1
Ihemelandu, C1
Vychnevskaia, K1
Dumont, F1
Agostini, J1
Julié, C1
Dartigues, P1
Lazure, T1
Boige, V2
Goéré, D1
Brouquet, A1
Penna, C1
Peschaud, F1
Benoist, S1
Wei, C1
Yu, X1
Zhang, Y1
Liu, M1
Walls, A1
Bousamra, A1
Ramineni, M1
Hunt, K2
Buchholz, TA1
Valero, V2
Buzdar, AU7
Yang, W1
Brewster, AM1
Moulder, S1
Pusztai, L4
Hortobagyi, GN4
Higuchi, I1
Yasuda, T3
Yano, M1
Doki, Y1
Miyata, H1
Tatsumi, M1
Fukunaga, H1
Takiguchi, S1
Fujiwara, Y1
Hatazawa, J1
Monden, M1
Kuerer, HM2
Mejia, JA2
Gonzalez-Angulo, AM1
Esteva, FJ2
Dawood, SS1
Green, MC1
Rosenthal, DI1
Catalano, PJ1
Haller, DG1
Landry, JC1
Sigurdson, ER1
Spitz, FR2
Benson, AB1
Duffy, A1
Capanu, M1
Abou-Alfa, GK1
Huitzil, D1
Jarnagin, W1
Fong, Y1
D'Angelica, M1
Dematteo, RP1
Blumgart, LH1
O'Reilly, EM1
Kim, MK1
Cho, KJ1
Park, SI1
Kim, YH1
Song, HY1
Shin, JH1
Jung, HY1
Lee, GH1
Choi, KD1
Song, HJ1
Ryu, JS1
Kim, SB1
Daliani, DD1
Tannir, NM1
Papandreou, CN1
Wang, X1
Swisher, S1
Wood, CG1
Swanson, DA1
Logothetis, CJ1
Jonasch, E1
Tanaka, K3
Otake, K1
Mohri, Y1
Ohi, M1
Yokoe, T2
Toiyama, Y3
Miki, C2
Tonouchi, H1
Kusunoki, M3
Kersting, S1
Konopke, R1
Dittert, D1
Distler, M1
Rückert, F1
Gastmeier, J1
Baretton, GB1
Saeger, HD1
Saigusa, S2
Okugawa, Y2
Ioue, Y1
Dose-Schwarz, J1
Tiling, R1
Avril-Sassen, S1
Mahner, S1
Lebeau, A1
Weber, C1
Schwaiger, M1
Jänicke, F1
Untch, M1
Avril, N1
Hillel, AT1
Fakhry, C1
Pai, SI1
Williams, MF1
Blanco, RG1
Zinreich, ES1
Levine, MA1
Westra, WH1
Saunders, JR1
Ha, PK1
Park, JH1
Choi, EK1
Ahn, SD2
Lee, SW1
Song, SY1
Yoon, SM1
Kim, YS1
Lee, YS1
Lee, SG1
Hwang, S1
Lee, YJ1
Park, KM1
Kim, TW1
Chang, HM1
Lee, JL1
Lordick, F1
Grenacher, L1
Röcken, C1
Ebert, M1
Moehler, M1
Schumacher, G1
Li, SP1
Taylor, NJ1
Makris, A3
Ah-See, ML2
Beresford, MJ2
Stirling, JJ1
d'Arcy, JA1
Collins, DJ1
Padhani, AR1
Oberholzer, K1
Menig, M1
Kreft, A1
Schneider, A1
Junginger, T1
Heintz, A1
Kreitner, KF1
Hötker, AM1
Hansen, T1
Düber, C1
Schmidberger, H1
Clavel, S1
Charron, MP1
Bélair, M1
Delouya, G1
Fortin, B1
Després, P1
Soulières, D1
Filion, E1
Guertin, L1
Nguyen-Tan, PF1
Lambregts, DM1
Vandecaveye, V1
Barbaro, B1
Bakers, FC1
Lambrecht, M1
Maas, M1
Haustermans, K1
Valentini, V1
Beets, GL1
Beets-Tan, RG1
Giorda, G1
Boz, G1
Gadducci, A1
Lucia, E1
De Piero, G1
De Paoli, A1
Innocente, R1
Trovò, M1
Sorio, R1
Campagnutta, E1
Swisher, SG1
Winter, KA1
Komaki, RU1
Ajani, JA1
Wu, TT1
Hofstetter, WL1
Konski, AA1
Willett, CG2
Zambetti, M1
Mansutti, M1
Gomez, P1
Lluch, A1
Dittrich, C1
Zamagni, C1
Ciruelos, E1
Pavesi, L1
Semiglazov, V1
De Benedictis, E1
Gaion, F1
Bari, M1
Morandi, P1
Valagussa, P1
Luca, G1
Dalton, RS1
Velineni, R1
Osborne, ME1
Thomas, R1
Harries, S1
Gee, AS1
Daniels, IR1
Roy, P1
Serra, S1
Kennedy, E1
Chetty, R1
Zapf, I1
Tizedes, G1
Pavlovics, G1
Kovács, G1
Kálmán, E1
Szalai, G1
Kövér, E1
Farkas, R1
Horváth, OP1
Fujikawa, H1
Matsushita, K1
Uchida, K1
Inoue, Y1
Soltys, SG1
Choi, CY1
Fee, WE1
Pinto, HA1
Le, QT1
Seehaus, A1
Vacaro, C1
Ocantos, J1
Varela, A1
Savluk, L1
Ojea Quintana, G1
Rossi, G1
Weimbaur, V1
Pablo Santino, J1
García-Mónaco, R1
Ferrero, A1
Langella, S1
Russolillo, N1
Vigano', L1
Lo Tesoriere, R1
Capussotti, L1
Arvold, ND1
Fernandez-del Castillo, C1
Ryan, DP1
Ferrone, CR1
Clark, JW1
Blaszkowsky, LS1
Deshpande, V1
Niemierko, A1
Allen, JN1
Kwak, EL1
Wadlow, RC1
Zhu, AX1
Warshaw, AL1
Hong, TS1
Bentzen, AG1
Guren, MG1
Wanderås, EH1
Frykholm, G1
Tveit, KM1
Wilsgaard, T1
Dahl, O1
Balteskard, L1
Arrazubi, V1
Suárez, J1
Guerrero, D1
Gómez, M1
Viúdez, A1
Arias, F1
Balén, E1
Vera, R1
Waseda, Y1
Komai, Y1
Yano, A1
Fujii, Y1
Noguchi, N1
Kihara, K1
Perez, RO1
Habr-Gama, A1
Lynn, PB1
São Julião, GP1
Bianchi, R1
Proscurshim, I1
Gama-Rodrigues, J1
Beriwal, S1
Shukla, G1
Shinde, A1
Heron, DE1
Kelley, JL1
Edwards, RP1
Sukumvanich, P1
Richards, S1
Olawaiye, AB1
Krivak, TC1
Zanoni, A1
Verlato, G1
Giacopuzzi, S1
Weindelmayer, J1
Casella, F1
Pasini, F1
Zhao, E1
de Manzoni, G1
Datta, NR1
Nagar, YS1
Singh, S1
Naryan, L1
Lin, JC2
Jan, JS2
Chen, KY1
Hsu, CY2
Liang, WM1
Wang, WY1
Nishimura, Y1
Koike, R1
Nakamatsu, K1
Kanamori, S1
Suzuki, M1
Shigeoka, H1
Shiozaki, H1
Lim, JT1
Truong, PT1
Berthelet, E1
Pai, H1
Joe, H1
Wai, E1
Larsson, S1
Kader, HA1
Weinerman, B1
Wilson, K1
Olivotto, IA1
Rajan, R1
Poniecka, A1
Smith, TL1
Yang, Y1
Frye, D1
Fiterman, DJ1
Gal-Gombos, E1
Whitman, G1
Rouzier, R1
Green, M1
Kuerer, H1
Elias, D1
Sideris, L1
Pocard, M1
Edè, C1
Ben Hassouna, D1
Ducreux, M1
Côté, JF1
Lasser, P1
van Tinteren, H1
van Ruth, S1
Zoetmulder, FA1
Bathe, OF1
Dowden, S1
Sutherland, F1
Dixon, E1
Butts, C1
Bigam, D1
Walley, B1
Ruether, D1
Ernst, S1
Altundag, O1
Gullu, I1
Altundag, K2
Yalcin, S1
Ozyar, E1
Cengiz, M1
Akyol, F1
Yucel, T1
Hosal, S1
Sozeri, B1
Denis, F1
Desbiez-Bourcier, AV1
Chapiron, C1
Arbion, F1
Body, G1
Brunereau, L1
Klug, C1
Wutzl, A1
Kermer, C1
Ploder, O1
Sulzbacher, I1
Selzer, E1
Voracek, M1
Oeckher, M1
Ewers, R1
Millesi, W1
Vironen, J1
Juhola, M1
Kairaluoma, M1
Jantunen, I1
Kellokumpu, I1
Warnecke-Eberz, U1
Hokita, S1
Xi, H1
Higashi, H2
Baldus, SE1
Metzger, R1
Brabender, J1
Bollschweiler, E1
Mueller, RP1
Dienes, HP1
Hoelscher, AH1
Schneider, PM1
O'Connor, JK1
Sause, WT1
Hazard, LJ1
Belnap, LP1
Noyes, RD1
Mawdsley, S1
Glynne-Jones, R1
Grainger, J1
Richman, P1
Harrison, M1
Ashford, R1
Harrison, RA1
Osborne, M1
Livingstone, JI1
MacDonald, P1
Mitchell, IC1
Meyrick-Thomas, J1
Northover, JM1
Windsor, A1
Novell, R1
Wallace, M1
Douek, M1
Tobias, J1
Ambrosini-Spaltro, A1
Salvi, F1
Betts, CM1
Frezza, GP1
Piemontese, A1
Del Prete, P1
Baldoni, C1
Foschini, MP1
Viale, G1
Chagpar, AB1
Middleton, LP1
Sahin, AA1
Dempsey, P1
Mirza, AN1
Ames, FC2
Babiera, GV1
Feig, BW2
Hunt, KK2
Meric-Bernstam, F1
Ross, MI2
Singletary, SE3
Chmielik, E1
Nasierowska-Guttmejer, A1
Nowacki, MP1
Kepka, L1
Sopylo, R1
Wojnar, A1
Majewski, P1
Sygut, J1
Karmolinski, A1
Huzarski, T1
Wandzel, P1
Tinari, N1
Lattanzio, R1
Natoli, C1
Cianchetti, E1
Angelucci, D1
Ricevuto, E1
Ficorella, C1
Marchetti, P1
Alberti, S1
Piantelli, M1
Iacobelli, S1
Lee, MJ1
Ra, YS1
Park, JB1
Goo, HW1
Khang, SK1
Song, JS1
Kim, YJ1
Ghim, TT1
Calvo, FA1
Aldaz, A1
Zufía, L1
de la Mata, D1
Serrano, J1
García, R1
Arranz, JA1
Alvarado, A1
Giráldez, J1
Burcombe, R1
Stott, D1
Dequanter, D1
Lothaire, P1
Awada, A1
Lalami, Y1
Hien Nguyen, T1
Lemort, M1
Vandevelde, L1
Andry, G1
Baghi, M1
Mack, MG1
Hambek, M1
Bisdas, S1
Muerthel, R1
Wagenblast, J1
Gstoettner, W1
Vogl, T1
Knecht, R1
Yang, JJ1
Xiang, Y1
Wan, XR1
Li, JG1
Yang, XY1
Brackstone, M1
Townson, JL1
Chambers, AF1
Lin, D1
Glastonbury, CM1
Rafaelian, O1
Eisele, DW1
Wang, SJ1
Lin, F1
Yan, K1
Austin, JR1
Wong, FC1
Kim, EE1
Tsuji, Y3
Nishimura, A2
Katsuki, Y3
Rice, TW2
Adelstein, DJ2
Koka, A1
Tefft, M1
Kirby, TJ1
Van Kirk, MA1
Taylor, ME1
Olencki, TE1
Peereboom, D1
Budd, GT1
Kent, AL1
Eaton, M1
Marshall, N1
Humeniuk, V1
Girvin, GW1
Matsumoto, GH1
Bates, DM1
Garcia, JM1
Clyde, JC1
Lin, PH1
Ito, H1
Ogawa, T1
Murayama, M1
Fujino, K1
Horii, H1
Imai, J1
Kobayashi, H1
Yamada, S1
Watanabe, C1
Ishiyama, M1
Furukawa, Y1
Otani, Y2
Ihara, A1
Tsuji, R1
Okamura, R1
Sato, K1
Hiki, Y1
Matsumoto, M1
Machida, T1
Kitazaki, M1
Ishihara, S1
Noma, M1
Ota, M1
Ban, K1
Masuda, K1
Shida, H1
Braly, PS1
Berek, JS1
Blessing, JA1
Homesley, HD1
Averette, H1
Hoshino, M1
Koyama, Y1
Igarashi, W1
Ohtake, T1
Ono, T1
Sato, N1
Hatakeyama, Y1
Abe, R1
Tono, T1
Tamaki, Y1
Yagyu, T2
Mishima, H2
Nakagawa, H1
Cho, G1
Shin, E2
Kobayashi, K2
Takatsuka, Y1
Kikkawa, N2
Takahashi, K1
Mori, T1
Takahashi, T2
Takano, S1
Moriguchi, M1
Seki, N1
Higaki, T1
Watanabe, Y1
Ito, Y1
Oishi, H1
Nakata, Y1
Kono, S1
Bates, BA1
Detterbeck, FC1
Bernard, SA1
Qaqish, BF1
Tepper, JE1
Helvie, MA1
Joynt, LK1
Cody, RL1
Pierce, LJ1
Adler, DD1
Merajver, SD1
Zinzani, PL1
Zompatori, M1
Bendandi, M1
Battista, G1
Fanti, S1
Barbieri, E1
Gherlinzoni, F1
Rimondi, MR1
Frezza, G1
Pisi, P1
Merla, E1
Gozzetti, A1
Canini, R1
Monetti, N1
Babini, L1
Tura, S1
Flam, M1
John, M1
Pajak, TF1
Petrelli, N1
Myerson, R1
Doggett, S1
Quivey, J1
Rotman, M1
Kerman, H1
Coia, L1
Murray, K1
Yanagi, I1
Koga, A1
Okuda, K1
Nishio, T1
Shibata, J1
Aso, K1
Matuo, H1
Nagashima, J1
So, H1
Nakayama, T1
Hasuike, Y1
Fukuda, K1
Kobayashi, T1
Gunderson, LL2
Nelson, H1
Martenson, JA2
Cha, S1
Haddock, M1
Devine, R1
Fieck, JM1
Wolff, B1
Dozois, R1
O'Connell, MJ1
Swaminathan, R1
Burch, PA1
Santala, RG1
Schroeder, G1
Pitot, HC1
Wright, K1
Kugler, JW1
Stella, PJ1
Garton, GR1
Kling, KM1
Ostrzega, N1
Schmit, P1
Matsumoto, N1
Umekita, N1
Maeshiro, T1
Miyamoto, S1
Awane, Y1
Miki, H1
Shibata, N1
Noguchi, S1
Tamai, M1
Hamada, H1
Hashimoto, M1
Kujime, J1
Yamagami, H1
Tomita, I1
Kimura, J1
Ohira, S1
Giacco, GG1
Hess, K1
Larry, L1
Rich, TA2
Janjan, N1
Cleary, KR2
Skibber, JM1
Zuccaro, G1
Goldblum, J1
Medendorp, SV1
Becker, M1
Pimentel, R1
Gitlin, L1
Janjan, NA1
Khoo, VS1
Abbruzzese, J1
Pazdur, R1
Dubrow, R1
Allen, PK2
Lynch, PM1
Glober, G1
Wolff, R1
Skibber, J1
Takanishi, K1
Matsumoto, J1
Minami, T1
Carr, JA1
Ajlouni, M1
Wollner, I1
Wong, D1
Velanovich, V1
Mohiuddin, M2
Regine, WF2
John, WJ1
Hagihara, PF2
McGrath, PC1
Kenady, DE1
Marks, G1
Vlastos, G1
Mirza, NQ1
Lenert, JT1
Liao, Z1
Strom, EA1
McNeese, MD1
Hayne, M1
Hanna, N1
McGrath, P1
Marks, GM1
Mehta, VK1
Fisher, GA1
Ford, JM1
Oberhelman, HA1
Vierra, MA1
Bastidas, AJ1
Poen, JC1
Brown, RS1
McCormack, M1
Lankester, KJ1
Spittle, MF1
Witte, RS1
Cnaan, A1
Mansour, EG1
Barylak, E1
Harris, JE1
Schutt, AJ1
Dunne, B1
Reynolds, JV1
Mulligan, E1
Kelly, A1
Griffin, M1
Onaitis, MW1
Noone, RB1
Fields, R1
Hurwitz, H1
Morse, M1
Jowell, P1
McGrath, K1
Lee, C1
Anscher, MS1
Clary, B1
Mantyh, C1
Pappas, TN1
Ludwig, K1
Seigler, HF1
Tyler, DS1
Kresl, JJ1
Schild, SE1
Henning, GT1
Donohue, J1
Pitot, H1
Haddock, MG1
Nagorney, D1

Clinical Trials (12)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomized Controlled Trial of the Efficacy of Adjuvant Chemotherapy in Patients With Residual Lesions After Concurrent Radiochemotherapy for Locally Advanced Cervical Cancer[NCT04409860]120 participants (Anticipated)Interventional2020-05-26Recruiting
A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice[NCT01460745]60 participants (Actual)Observational2011-11-30Completed
Neoadjuvant FOLFIRINOX and Chemoradiation Followed by Definitive Surgery and Postoperative Gemcitabine for Patients With Borderline Resectable Pancreatic Adenocarcinoma: An Intergroup Single-Arm Pilot Study[NCT01821612]Early Phase 123 participants (Actual)Interventional2013-05-31Completed
A Study of Preoperative FOLFIRINOX For Potentially Curable Pancreatic Cancer[NCT03167112]Phase 220 participants (Anticipated)Interventional2017-07-03Recruiting
Follow up and Functional Outcome of Organ Saving Treatment in Patients With Good Response to Neo-adjuvant (Chemo)Radiation for Rectal Cancer[NCT02278653]100 participants (Anticipated)Observational [Patient Registry]2014-03-31Active, not recruiting
Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer[NCT01721785]307 participants (Actual)Observational2012-10-31Completed
A Phase II Study Of Paclitaxel-Based Chemoradiotherapy Regimen With Selective Surgical Salvage For Resectable Locoregionally Advanced Carcinoma Of The Esophagus[NCT00069953]Phase 243 participants (Actual)Interventional2003-09-30Completed
"Radical External Beam Chemoradiation in Patients With Rectal Cancer: a Wait-and-see Approach"[NCT03001362]48 participants (Anticipated)Interventional2015-03-31Recruiting
A Phase III Clinical Trial of Docetaxel Plus Cisplatin Versus Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma[NCT02465736]Phase 3610 participants (Anticipated)Interventional2015-07-31Recruiting
Long-term Results of Plasma Epstein-Barr Virus DNA Monitoring In Nasopharyngeal Carcinoma After Curative Treatment[NCT03973723]441 participants (Actual)Observational2011-08-01Completed
Prospective Clinical Trial to Assess a Mini-invasive Pre-surgical Procedure to Detect Residual Breast or Axillary Disease in Patients With cT1-T2-T3 cN0/N1 Breast Cancer in Complete Clinical/Radiological Remission After Primary Chemotherapy[NCT05951699]105 participants (Anticipated)Observational2022-04-28Recruiting
Early Assessment of Shear Wave Elastography Parameters to Assess the Response to Neoadjuvant Chemotherapy in Patients With Invasive Breast Cancer[NCT05068999]35 participants (Anticipated)Observational2021-12-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Overall Survival (1-year Rate Reported)

One-year survival estimate is reported. Survival time is defined as time from registration to date of death from any cause and is estimated by the Kaplan-Meier method. Patients last known to be alive are censored at date of last contact. This analysis was planned to occur when all patients had been potentially followed for 1 year. On the basis of a 1-year survival rate of 60% from the Radiation Therapy Oncology Group (RTOG) esophageal database, 38 analyzable patients with a 1-year survival rate of 77.5% or better was needed for this trial to be deemed promising enough for development of a Phase III protocol (type I error of 0.05 and type II error of 0.20). (NCT00069953)
Timeframe: From registration to date of death or last follow-up. Analysis occurs after all patients have been potentially followed for 1 year.

Interventionpercentage of participants (Number)
ChemoRT and Selective Surgery71

Reviews

4 reviews available for fluorouracil and Minimal Disease, Residual

ArticleYear
Appendiceal tumors with glandular and neuroendocrine features exhibiting peritoneal metastases - Critical evaluation of outcome following cytoreductive surgery with perioperative chemotherapy.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2021, Volume: 47, Issue:6

    Topics: Adenocarcinoma; Administration, Intravenous; Adult; Aged; Antineoplastic Combined Chemotherapy Proto

2021
Anal cancer treatment: current status and future perspectives.
    World journal of gastroenterology, 2015, Feb-28, Volume: 21, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; C

2015
[Diagnosis and treatment of gastric cancer].
    Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:34-35

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Signet Ring Cell; Cisplatin; Endo

2010
Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc

1996

Trials

41 trials available for fluorouracil and Minimal Disease, Residual

ArticleYear
Minimal Residual Disease-Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-US.
    Oncology (Williston Park, N.Y.), 2022, 10-07, Volume: 36, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Circulating Tumor DNA; Clinical Trials

2022
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer.
    International journal of cancer, 2020, 11-01, Volume: 147, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast; Breast Neoplasms; Chemot

2020
Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer.
    Journal of the National Cancer Institute, 2017, 12-01, Volume: 109, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy, Adjuvant; Disease-Free

2017
Five fractions of radiation therapy followed by 4 cycles of FOLFOX chemotherapy as preoperative treatment for rectal cancer.
    International journal of radiation oncology, biology, physics, 2014, Mar-15, Volume: 88, Issue:4

    Topics: Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Dose Fractionation, Radiation; Drug Admi

2014
Prognostic Factors in Patients Receiving Neoadjuvant 5-Fluorouracil plus Cisplatin for Advanced Esophageal Cancer (JCOG9907).
    Oncology, 2015, Volume: 89, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy,

2015
Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2015, Volume: 28, Issue:7

    Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chemotherapy,

2015
Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2016, Volume: 42, Issue:2

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiot

2016
A Feasibility Study of Neoadjuvant XELOX Without Radiotherapy for Locally Advanced Lower Rectal Cancer.
    Anticancer research, 2016, Volume: 36, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcin

2016
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
    JAMA surgery, 2016, 08-17, Volume: 151, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Carcinoma, Pancrea

2016
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
    JAMA surgery, 2016, 08-17, Volume: 151, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Carcinoma, Pancrea

2016
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
    JAMA surgery, 2016, 08-17, Volume: 151, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Carcinoma, Pancrea

2016
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
    JAMA surgery, 2016, 08-17, Volume: 151, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Carcinoma, Pancrea

2016
Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
    The Journal of thoracic and cardiovascular surgery, 2008, Volume: 136, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy,

2008
Phase I study of preoperative radiation therapy with concurrent infusional 5-fluorouracil and oxaliplatin followed by surgery and postoperative 5-fluorouracil plus leucovorin for T3/T4 rectal adenocarcinoma: ECOG E1297.
    International journal of radiation oncology, biology, physics, 2008, Sep-01, Volume: 72, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Thera

2008
Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:5

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chem

2009
Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.
    British journal of cancer, 2010, Jan-05, Volume: 102, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclo

2010
Multimodality approach in extra cervical locally advanced cervical cancer: chemoradiation, surgery and intra-operative radiation therapy. A phase II trial.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2011, Volume: 37, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Dist

2011
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.
    International journal of radiation oncology, biology, physics, 2012, Apr-01, Volume: 82, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc

2012
Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II).
    Breast cancer research and treatment, 2012, Volume: 132, Issue:3

    Topics: Adult; Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capec

2012
Loco-regional failures in head and neck cancer: can they be effectively salvaged by nonsurgical therapeutic modalities?
    International journal of clinical oncology, 2003, Volume: 8, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Follow

2003
Endoscopic response predicts for survival and organ preservation after primary chemoradiotherapy for esophageal cancer.
    International journal of radiation oncology, biology, physics, 2003, Dec-01, Volume: 57, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma,

2003
Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response.
    Cancer, 2004, Apr-01, Volume: 100, Issue:7

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; B

2004
Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:5

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Mo

2004
Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy.
    The British journal of surgery, 2004, Volume: 91, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Colo

2004
Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma.
    BMC cancer, 2004, Jul-10, Volume: 4

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cause of

2004
Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients.
    Head & neck, 2005, Volume: 27, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Di

2005
Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2004, Volume: 30, Issue:10

    Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylati

2004
How reliable is MRI for predicting extent of residual breast cancer with different primary medical therapies?
    Nature clinical practice. Oncology, 2005, Volume: 2, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Docet

2005
Distal intramural spread of rectal cancer after preoperative radiotherapy: the results of a multicenter randomized clinical study.
    International journal of radiation oncology, biology, physics, 2006, May-01, Volume: 65, Issue:1

    Topics: Adult; Aged; Anal Canal; Antimetabolites, Antineoplastic; Chi-Square Distribution; Combined Modality

2006
Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children.
    Journal of neuro-oncology, 2006, Volume: 80, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool

2006
Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2006, Volume: 18, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dat

2006
[Preventive chemotherapy for residual liver after resection of hepatic metastasis from colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:11

    Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Hu

1995
Treating esophageal cancer with a combination of chemotherapy, radiation, and excision.
    American journal of surgery, 1995, Volume: 169, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel

1995
[Effect of prophylactic intra-arterial infusion of anticancer drugs on post hepatic resection for hepatic metastasis of colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21 Suppl 4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administrati

1994
Intraperitoneal administration of cisplatin and 5-fluorouracil in residual ovarian cancer: a Phase II Gynecologic Oncology Group trial.
    Gynecologic oncology, 1995, Volume: 56, Issue:2

    Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protoc

1995
[Efficacy of intrahepatic arterial chemotherapy to prevent recurrence of residual liver in metastatic liver cancer patients after hepatectomy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Epirubicin; Female; Fluorou

1994
[Evaluation of prophylactic intra-hepatic-arterial infusion chemotherapy after resection of hepatic metastases from colorectal primaries].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Do

1994
[Hepatic arterial infusion after hepatectomy for liver metastases of colorectal carcinoma to prevent residual hepatic recurrence].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Floxuridine; Flu

1994
[The significance of portal infusion chemotherapy for prevention of recurrence in residual liver after hepatectomy for metastases from colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Female; Fluorouracil; He

1994
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 1996, Volume: 22, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1996
Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Cisplatin;

1996
[Evaluation of prophylactic hepatic arterial infusion chemotherapy after hepatectomy for metastases from colorectal cancer--the second report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11

    Topics: Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Hepatectomy; Hepatic Artery; Human

1996
[The preventive effect of weekly high-dose 5-FU infusion (WHF) after resection of hepatic metastasis from colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11

    Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorouracil; H

1996
Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Cancer, 2001, Mar-01, Volume: 91, Issue:5

    Topics: Abdominal Neoplasms; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antineoplastic Combined

2001

Other Studies

108 other studies available for fluorouracil and Minimal Disease, Residual

ArticleYear
Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome.
    Asian Pacific journal of cancer prevention : APJCP, 2022, Feb-01, Volume: 23, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Disease-

2022
YpN0 rectal cancer patients with sterilized lymph nodes after neoadjuvant chemoradiotherapy are of greater risk of recurrence.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2020, Volume: 52, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, A

2020
Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    BJS open, 2019, Volume: 3, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Disease-Free Surv

2019
Topical Fluorouracil Therapy for Residual Superficial Basal Cell Carcinoma Following Mohs Micrographic Surgery.
    Journal of drugs in dermatology : JDD, 2020, May-01, Volume: 19, Issue:5

    Topics: Administration, Cutaneous; Aged; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Female; Fluorouracil

2020
Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation.
    CA: a cancer journal for clinicians, 2021, Volume: 71, Issue:3

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoembryonic

2021
Analysis of Perioperative Chemotherapy in Resected Pancreatic Cancer: Identifying the Number and Sequence of Chemotherapy Cycles Needed to Optimize Survival.
    Annals of surgical oncology, 2017, Volume: 24, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Female;

2017
Appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2017, Sep-01, Volume: 30, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous

2017
Resection of Locally Advanced Pancreatic Cancer without Regression of Arterial Encasement After Modern-Era Neoadjuvant Therapy.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2018, Volume: 22, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Arteries; Celiac Artery; Chemo

2018
Neoadjuvant chemoradiation for non-metastatic pancreatic cancer increases margin-negative and node-negative rates at resection.
    Journal of digestive diseases, 2017, Volume: 18, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap

2017
Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
    Annals of surgical oncology, 2018, Volume: 25, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva

2018
Efficacy of anti-PD-1 therapy in a patient with brain metastasis of parotid carcinoma: A case report.
    Auris, nasus, larynx, 2019, Volume: 46, Issue:5

    Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Brain Ne

2019
Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After Chemoradiation.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2019, Volume: 23, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cohort Studies; F

2019
Early recurrence detected in hepatocellular carcinoma patients after transcatheter arterial chemoembolization treatment with plasma cell-free DNA.
    European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoemboliz

2019
ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Anticancer research, 2019, Volume: 39, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy, Adjuvant; Disease-Free Survival; DNA-Binding Prot

2019
Prognostic significance of pathological tumor response and residual nodal metastasis in patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery.
    Esophagus : official journal of the Japan Esophageal Society, 2019, Volume: 16, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy,

2019
Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2019, 06-01, Volume: 17, Issue:6

    Topics: Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Bile Duc

2019
Feasibility of an adaptive strategy in preoperative radiochemotherapy for rectal cancer with image-guided tomotherapy: boosting the dose to the shrinking tumor.
    International journal of radiation oncology, biology, physics, 2013, Sep-01, Volume: 87, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Dose Fractionation,

2013
Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: results of a multicenter study.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2013, Volume: 39, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradi

2013
Long-term monitoring of serum p53 antibody after neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: report of a case.
    Surgery today, 2014, Volume: 44, Issue:10

    Topics: Adenocarcinoma; Aged; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor;

2014
The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy.
    American journal of clinical oncology, 2016, Volume: 39, Issue:2

    Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplati

2016
[Adjuvant chemoradiotherapy in advanced gastric cancer: experience in 168 patients].
    Revista medica de Chile, 2014, Volume: 142, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Fe

2014
Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2014, Volume: 112, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineopl

2014
Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery.
    Anticancer research, 2014, Volume: 34, Issue:11

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Chemora

2014
Chemotherapy of WAP-T mouse mammary carcinomas aggravates tumor phenotype and enhances tumor cell dissemination.
    International journal of cancer, 2015, Jul-01, Volume: 137, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cyclo

2015
Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiation.
    Digestion, 2014, Volume: 90, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino

2014
Prognostic factors in operable breast cancer treated with neoadjuvant chemotherapy: towards a quantification of residual disease.
    Oncology, 2015, Volume: 88, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Brea

2015
Liver resection rate following downsizing chemotherapy with cetuximab in metastatic colorectal cancer: UK retrospective observational study.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptotheci

2015
Association between the thoroughness of the histopathological examination and survival in patients with esophageal squamous cell carcinoma who achieve pathological complete response after chemoradiotherapy.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2016, Volume: 29, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiothe

2016
Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy.
    Clinical breast cancer, 2015, Volume: 15, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cis

2015
[Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
    Bulletin du cancer, 2016, Volume: 103, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C

2016
Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress.
    Oncotarget, 2016, May-03, Volume: 7, Issue:18

    Topics: Anaphase-Promoting Complex-Cyclosome; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Li

2016
Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer.
    European journal of cancer (Oxford, England : 1990), 2016, Volume: 69

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast;

2016
Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
    Annals of surgical oncology, 2017, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarke

2017
Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer.
    Annals of surgical oncology, 2017, Volume: 24, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Disease-Free Surv

2017
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Apr-01, Volume: 35, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosp

2017
Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineopl

2008
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).
    Journal of surgical oncology, 2008, Dec-01, Volume: 98, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvan

2008
Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy.
    International journal of radiation oncology, biology, physics, 2009, Sep-01, Volume: 75, Issue:1

    Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Car

2009
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma.
    BJU international, 2009, Volume: 104, Issue:4

    Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; C

2009
Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer.
    Oncology reports, 2009, Volume: 21, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Squamous

2009
Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
    Annals of surgical oncology, 2009, Volume: 16, Issue:12

    Topics: AC133 Antigen; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers

2009
Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2009, Volume: 141, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chi-Square Distribution; C

2009
Postoperative chemoradiotherapy for extrahepatic bile duct cancer.
    International journal of radiation oncology, biology, physics, 2011, Mar-01, Volume: 79, Issue:3

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; CA-19-9

2011
Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
    Radiology, 2010, Volume: 257, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biop

2010
Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
    International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma

2012
The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer.
    International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2

    Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Decision

2012
Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
    American journal of clinical oncology, 2012, Volume: 35, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; B

2012
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
    Annals of surgical oncology, 2011, Volume: 18, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemor

2011
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
    Annals of surgical oncology, 2011, Volume: 18, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemor

2011
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
    Annals of surgical oncology, 2011, Volume: 18, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemor

2011
Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.
    Annals of surgical oncology, 2011, Volume: 18, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemor

2011
A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management?
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2012, Volume: 14, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Chemoradiotherapy; De

2012
The prognostic value of grade of regression and oncocytic change in rectal adenocarcinoma treated with neo-adjuvant chemoradiotherapy.
    Journal of surgical oncology, 2012, Volume: 105, Issue:2

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem

2012
[Primary systemic therapy in breast cancer patients (2007-2010)].
    Magyar sebeszet, 2011, Volume: 64, Issue:5

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms;

2011
Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy.
    Surgery today, 2012, Volume: 42, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Ch

2012
A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy.
    International journal of radiation oncology, biology, physics, 2012, Jul-01, Volume: 83, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous

2012
[Diffusion-weighted MR imaging in patients with rectal cancer: our initial experience].
    Acta gastroenterologica Latinoamericana, 2011, Volume: 41, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Diffusion Magnetic Resonance Imagin

2011
Intraoperative detection of disappearing colorectal liver metastases as a predictor of residual disease.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2012, Volume: 16, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma; Chi-Square Distributi

2012
Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy.
    International journal of radiation oncology, biology, physics, 2012, Jul-01, Volume: 83, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Dose F

2012
Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort.
    International journal of radiation oncology, biology, physics, 2012, Jun-01, Volume: 83, Issue:2

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Ne

2012
Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013, Volume: 15, Issue:4

    Topics: 3' Untranslated Regions; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy

2013
Pathological complete response and two-year disease-free survival in a primary gastric choriocarcinoma patient with advanced liver metastases treated with germ cell tumor-based chemotherapy: a case report.
    Japanese journal of clinical oncology, 2012, Volume: 42, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Choriocarcinoma, Non-gestat

2012
Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Diseases of the colon and rectum, 2013, Volume: 56, Issue:1

    Topics: Adenocarcinoma; Aged; Anal Canal; Brazil; Chemoradiotherapy; Female; Fluorouracil; Humans; Male; Mic

2013
Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse.
    International journal of radiation oncology, biology, physics, 2013, Apr-01, Volume: 85, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous

2013
Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center.
    Annals of surgical oncology, 2013, Volume: 20, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel

2013
Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
    Head & neck, 2003, Volume: 25, Issue:6

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma;

2003
Concurrent chemoradiotherapy with protracted infusion of 5-FU and cisplatin for postoperative recurrent or residual esophageal cancer.
    Japanese journal of clinical oncology, 2003, Volume: 33, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; D

2003
Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor.
    International journal of oral and maxillofacial surgery, 2005, Volume: 34, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Fe

2005
Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma.
    International journal of colorectal disease, 2005, Volume: 20, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv

2005
Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
    Oncology reports, 2005, Volume: 13, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel

2005
Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    International journal of radiation oncology, biology, physics, 2005, Nov-15, Volume: 63, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Ampulla of Vater; Chemotherapy, Adjuvant; Combined M

2005
Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?
    International journal of radiation oncology, biology, physics, 2005, Nov-01, Volume: 63, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplastic; Combined Moda

2005
Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy.
    Virchows Archiv : an international journal of pathology, 2006, Volume: 448, Issue:4

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Cell Transformation, Neopl

2006
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
    Annals of surgery, 2006, Volume: 243, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan

2006
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
    Annals of surgery, 2006, Volume: 243, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan

2006
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
    Annals of surgery, 2006, Volume: 243, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan

2006
Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.
    Annals of surgery, 2006, Volume: 243, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan

2006
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Mar-01, Volume: 12, Issue:5

    Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; C

2006
Tegafur and 5-fluorouracil pelvic tissue concentrations in rectal cancer patients receiving preoperative chemoradiation.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:7

    Topics: Adipose Tissue; Adult; Aged; Antimetabolites, Antineoplastic; Female; Fluorouracil; Humans; Intestin

2006
Does clinical and radiological response predict complete tumor control in N2-N3 squamous cell head and neck cancer after non-operative management of the neck?
    Acta oto-laryngologica, 2006, Volume: 126, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcino

2006
Usefulness of MRI volumetric evaluation in patients with squamous cell cancer of the head and neck treated with neoadjuvant chemotherapy.
    Head & neck, 2007, Volume: 29, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Do

2007
[Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
    Zhonghua fu chan ke za zhi, 2007, Volume: 42, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human;

2007
Tumour dormancy in breast cancer: an update.
    Breast cancer research : BCR, 2007, Volume: 9, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorour

2007
Management of advanced nodal disease following chemoradiation for head and neck squamous cell carcinoma: role of magnetic resonance imaging.
    The Journal of otolaryngology, 2007, Volume: 36, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous

2007
CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.
    Breast cancer research : BCR, 2007, Volume: 9, Issue:6

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chem

2007
Positron emission tomography in the detection of residual laryngeal carcinoma.
    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 1995, Volume: 113, Issue:4

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma,

1995
Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
    The Annals of thoracic surgery, 1995, Volume: 60, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cause o

1995
Locally advanced breast cancer: is surgery warranted following chemotherapy?
    The Australian and New Zealand journal of surgery, 1995, Volume: 65, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy;

1995
[Effects of 5-fluorouracil in shrinking residual gastric cancer: a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:7

    Topics: Adenocarcinoma; Aged; Fluorouracil; Gastrectomy; Humans; Male; Neoplasm, Residual; Remission Inducti

1995
[Home therapy approach in cancer patients-chemotherapy (case 2-1)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21 Suppl 4

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Fluorourac

1994
[A case of multiple liver metastasis from remnant gastric cancer responding to leucovorin.5-FU+UFT therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:4

    Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Adm

1995
Locally advanced breast carcinoma: accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy.
    Radiology, 1996, Volume: 198, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma,

1996
[Usefulness of continuous arterial infusion chemotherapy for post operative multiple recurrence and residual hepatocellular carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cisplatin; Drug Administr

1996
Preliminary report of outpatient weekly adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
    American journal of clinical oncology, 1996, Volume: 19, Issue:6

    Topics: Adult; Aged; Ambulatory Care; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic

1996
Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation +/- 5-FU.
    International journal of radiation oncology, biology, physics, 1997, Feb-01, Volume: 37, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Colonic Neoplasms; Combined Modalit

1997
Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer.
    International journal of radiation oncology, biology, physics, 1997, Feb-01, Volume: 37, Issue:3

    Topics: Antidotes; Antimetabolites, Antineoplastic; Colonic Neoplasms; Combined Modality Therapy; Fluorourac

1997
Breast conservation after induction chemotherapy for locally advanced breast cancer.
    The American surgeon, 1997, Volume: 63, Issue:10

    Topics: Age Factors; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Al

1997
[Liver abscess caused by hepatic artery infusion chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:12

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Colectomy; Colonic Neoplasms; Fluorouracil; Hepatec

1997
[A case of stage IVb gastric cancer effectively treated by neoadjuvant chemotherapy and total gastrectomy with no residual tumor (R0)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:14

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cispla

1997
[Intra-arterial preventive chemotherapy for residual liver after resection of hepatic metastasis from colorectal cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:9

    Topics: Antimetabolites, Antineoplastic; Colorectal Neoplasms; Drug Administration Schedule; Female; Fluorou

1998
p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Biopsy; Cell Dif

1997
Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:4

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin;

1999
Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience.
    International journal of radiation oncology, biology, physics, 1999, Jul-15, Volume: 44, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anal Canal; Antimetabolites, Antineoplastic; Combined Modality Thera

1999
[Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms

1999
Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.
    The American surgeon, 1999, Volume: 65, Issue:12

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Fluorouracil; Humans; Life

1999
Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.
    International journal of radiation oncology, biology, physics, 2000, Mar-01, Volume: 46, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Diarrhea

2000
The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy.
    Cancer, 2000, Mar-15, Volume: 88, Issue:6

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; An

2000
Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.
    International journal of radiation oncology, biology, physics, 2000, Jul-15, Volume: 47, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvan

2000
Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers.
    International journal of radiation oncology, biology, physics, 2000, Nov-01, Volume: 48, Issue:4

    Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies;

2000
Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer.
    International journal of radiation oncology, biology, physics, 2000, Dec-01, Volume: 48, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Cohort Studies; Drug Administration Sche

2000
Spontaneous apparent clinical resolution with histologic persistence of a case of extramammary Paget's disease: response to topical 5-fluorouracil.
    Cutis, 2000, Volume: 66, Issue:6

    Topics: Anus Neoplasms; Dose Fractionation, Radiation; Female; Fluorouracil; Follow-Up Studies; Humans; Neop

2000
A pathological study of tumour regression in oesophageal adenocarcinoma treated with preoperative chemoradiotherapy.
    Journal of clinical pathology, 2001, Volume: 54, Issue:11

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem

2001
Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival.
    Annals of surgical oncology, 2001, Volume: 8, Issue:10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Colectomy;

2001
Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma.
    International journal of radiation oncology, biology, physics, 2002, Jan-01, Volume: 52, Issue:1

    Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Carcinoma, Adenosquamous; Female; Fluorouraci

2002